Macerich Q1 2026 Earnings EPS Misses Estimates by 26 as Mall REIT Struggles PENN Q1 2026 Earnings EPS Misses Estimates as Stock Surges 119 Vistagen Therapeutics VTGN Q1 2026 Earnings Narrowing Loss Beats Estimates as Pipeline Progress Continues ROG Q1 2026 Earnings Strong EPS Beat Surprises Market MGX Q1 2026 Earnings Missed Expectations as PreRevenue Biotech Advances Gene Editing Pipeline VZ Q1 2026 Earnings EPS Beat Expectations Amid Tight Cost Control